DK1232746T3 - Farmaceutisk sammensætning indeholdende xanthan gummi - Google Patents

Farmaceutisk sammensætning indeholdende xanthan gummi

Info

Publication number
DK1232746T3
DK1232746T3 DK01200507T DK01200507T DK1232746T3 DK 1232746 T3 DK1232746 T3 DK 1232746T3 DK 01200507 T DK01200507 T DK 01200507T DK 01200507 T DK01200507 T DK 01200507T DK 1232746 T3 DK1232746 T3 DK 1232746T3
Authority
DK
Denmark
Prior art keywords
xanthan gum
pharmaceutical composition
composition containing
containing xanthan
suspension
Prior art date
Application number
DK01200507T
Other languages
English (en)
Inventor
Peter Meijlink
De Lockand Petrus Richardu Van
Original Assignee
Forte Iq B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8179884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1232746(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Forte Iq B V filed Critical Forte Iq B V
Application granted granted Critical
Publication of DK1232746T3 publication Critical patent/DK1232746T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01200507T 2001-02-14 2001-02-14 Farmaceutisk sammensætning indeholdende xanthan gummi DK1232746T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01200507A EP1232746B1 (en) 2001-02-14 2001-02-14 Pharmaceutical composition comprising xanthan gum

Publications (1)

Publication Number Publication Date
DK1232746T3 true DK1232746T3 (da) 2006-10-23

Family

ID=8179884

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01200507T DK1232746T3 (da) 2001-02-14 2001-02-14 Farmaceutisk sammensætning indeholdende xanthan gummi

Country Status (7)

Country Link
EP (1) EP1232746B1 (da)
AT (1) ATE329578T1 (da)
CY (1) CY1105540T1 (da)
DE (1) DE60120630T2 (da)
DK (1) DK1232746T3 (da)
ES (1) ES2266084T3 (da)
PT (1) PT1232746E (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291015A1 (en) 2001-09-10 2003-03-12 Lunamed AG Dosage forms having prolonged active ingredient release
ES2245891B1 (es) * 2004-07-09 2006-11-16 Clinmet S.L. "metodo para la obtencion de un excipiente universal para la administracion oral de principios activos farmaceuticos y composiciones de excipientes resultantes del metodo".
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
FR2881321B1 (fr) 2005-02-03 2008-12-26 Axiss France Sas Soc Par Actio Additif alimentaire pour ruminants a base d'eugenol et de cinnamaldehyde
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
CN108096193A (zh) * 2017-12-26 2018-06-01 兆科药业（广州）有限公司 一种苯丁酸钠散剂及其制备方法
CN114432241B (zh) * 2021-12-21 2023-07-14 上海奥全生物医药科技有限公司 一种快速分散的助悬组合物、制备方法及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0394259A4 (en) * 1987-06-25 1991-04-17 Dentab, Inc. A tooth cleaning and fluoridating tablet
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
EP1475091A1 (en) * 1993-10-01 2004-11-10 Roche Palo Alto LLC Mycophenolate mofetil - high dose oral suspensions
GB9521707D0 (en) * 1995-10-24 1996-01-03 Zeneca Ltd Improved granule composition
US5712310A (en) * 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
US6074987A (en) * 1998-05-28 2000-06-13 Bayer Corporation Inhibiting phase separation in low viscosity water-based pesticide suspensions

Also Published As

Publication number Publication date
PT1232746E (pt) 2006-11-30
ATE329578T1 (de) 2006-07-15
EP1232746B1 (en) 2006-06-14
ES2266084T3 (es) 2007-03-01
DE60120630D1 (de) 2006-07-27
EP1232746A1 (en) 2002-08-21
DE60120630T2 (de) 2007-05-24
CY1105540T1 (el) 2010-07-28

Similar Documents

Publication Publication Date Title
NO20034230D0 (no) 1,2,3,4-tetrahydroisokinolin-derivater som urotensin II reseptor-antagonister
BR0215380A (pt) Pó micronizado farmacêutico ou nutracêutico de liberação imediata e utilização do mesmo
MY125651A (en) Eplerenone compositions
PT1257260E (pt) Formulacao de po
NZ504653A (en) Cosmetic compositions with dibenzylidene sorbitol and functionalized silicones
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
NO20024339D0 (no) 1,2,3,4-Tetrahydroisokinolin-derivater
ATE234634T1 (de) Feste pharmazeutische formulierungen enthaltend eine physische mischung aus sulphoalkylethercyclodextrin und einem therapeutischen wirkstoff
HRP20010463B1 (hr) Smjesa s kontroliranim otpuštanjem koja sadrži galantamin
EA200601588A1 (ru) Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств
SE9700135D0 (sv) New formulation
DE60128961D1 (de) Wasserfreie selbsterhitzende zusammensetzungen, insbesondere wasserfreie haarkonditioniermittel
IL162851A0 (en) 4-(Piperidyl-and pyrrolidyl-alkyl-ureido)-quinolines as urotensin ii receptor antagonists
MY137535A (en) New pyrrolidinium derivatives
BR9810985A (pt) Aplicação tópica de uma combinação de peróxido de benzoìla e um segundo ingrediente ativo
BR0214279A (pt) Composições farmacêuticas em forma particulada
MXPA03004780A (es) Nuevas sulfamidas.
WO2004026836A8 (en) 1-pyridin-4-yl-urea derivatives
EA200301275A1 (ru) Капсулы для ингаляции
BR0211736A (pt) Formulação para suspensão oral estabilizada
DE602005025083D1 (da)
CA2493176A1 (en) Viscous compositions containing hydrophobic liquids
DK1232746T3 (da) Farmaceutisk sammensætning indeholdende xanthan gummi
CO4900027A1 (es) Formulaciones en aerosol de furoato de mometasona sin cloro- fluorocarburos .
DE60025503D1 (de) Pharmazeutische Zusammensetzungen, die Faropenem Natrium und eine Diamineacetat Verbindung zur Verbesserung der Magen-Darm Trakt Absorption enthalten